Alan Stuttle

Alan has wide ranging experience of early stage companies in the healthcare sector.  He has been the founder and CEO of two companies.  One of these operates in the pharmaceutical arena (medicinal chemistry) with a global customer base whilst the other is a biotechnology company (immune system modulation) with a subsidiary in Asia Pacific.  Alan has previously managed an equity and investment portfolio covering medtech, pharmaceutical and biotech companies.  He is an accomplished negotiator with experience of licensing, M&A, IP protection and exploitation.  Alan is experienced in identifying, developing and implementing effective commercial strategies.

Alan has a degree in Applied Biology (Pharmacology), a PhD in Nuclear Medicine (London) and an MBA (Westminster).